Edwards Lifesciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.About EW
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.
EW Key Statistics
Stock Snapshot
The current Edwards Lifesciences(EW) stock price is $83.06, with a market capitalization of 48.68B. The stock trades at a price-to-earnings (P/E) ratio of 35.34.
On 2026-01-14, Edwards Lifesciences(EW) stock moved within a range of $82.39 to $83.60. With shares now at $83.06, the stock is trading +0.8% above its intraday low and -0.6% below the session's peak.
Trading activity shows a volume of 296.41K, compared to an average daily volume of 3.23M.
Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.
Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.
EW News
Edwards Lifesciences EW, following the sell-off of the Critical Care wing, looks forward to developing the most comprehensive structural heart portfolio. In TMT...
On Friday, the U.S. District Court for the District of Columbia granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking Edwar...
Baird raised the firm’s price target on Edwards Lifesciences (EW) to $90 from $87 and keeps a Neutral rating on the shares. The firm updated its model following...
Analyst ratings
69%
of 35 ratingsMore EW News
In a setback to medical-technology company Edward Lifesciences (EW), the U.S. District Court for the District of Columbia ruled in favor of the U.S. Federal Tra...
(RTTNews) - Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Columbia has granted the Federal Trade Commission's (FTC) motio...
TD Cowen upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $97, up from $90. The firm thinks the company has entered a renewed growth c...